Inventor · disambiguated record
Shannon Renae Morris
Also filed as: MORRIS SHANNON RENAE
3 granted patents·15 pending applications·1 citations·filing 2010–2024
50Inventor score
Top patents by PatentIndex Score
18 records- 0177US2025017947A1CombinationNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0263US8796298B2Combination of a B-Raf inhibitor: N-{3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1- dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide and the Akt inhibitor: N-{ (1S)-2-amino-1-[(3- fluorophenyl)methyl]ethyl}-5-chIoro-4-(4-chIoro- 1 -methyl- 1 H-pyrazol-5-yl)-2-10 thiophenecarboxamide useful in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Aug 5, 2014·1 cites·1 claims
- 0359US2015094321A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 0458US2014309243A1CombinationGLAXOSMITHKLINE LLC·Filed 2014·Application pending·0 cites
- 0557US2020222431A1CombinationNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0656US2018214451A1CombinationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0755US9402846B2Combination of inhibitor of B-Raf and inhibitor of AKT in the treatment of cancerNOVARTIS AG·Filed 2014·Granted Aug 2, 2016·0 cites·15 claims
- 0854US2016228456A1CombinationNOVARTIS AG·Filed 2014·Application pending·0 cites
- 0953US2018264008A1CombinationNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1050US2017239274A1CombinationNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1150US2016143913A1CombinationNOVARTIS AG·Filed 2016·Application pending·0 cites
- 1249US2016235714A1Enzalutamide in combination with afuresertib for the treatment of cancerNOVARTIS AG·Filed 2014·Application pending·0 cites
- 1348US2012283278A1CombinationDUMBLE MELISSA·Filed 2010·Application pending·0 cites
- 1447US2018344699A1Enzalutamide in combination with afuresertib for the treatment of cancerNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1545US8835450B2Combination of inhibitor of B-Raf and an inhibitor of Akt in the treatment of cancerDUMBLE MELISSA·Filed 2010·Granted Sep 16, 2014·0 cites·4 claims
- 1645US2018117011A1Enzalutamide in combination with afuresertib for the treatment of cancerNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1730US2012202822A1CombinationBACHMAN KURTIS EARL·Filed 2010·Application pending·0 cites
- 1821US2012245180A1CombinationAUGER KURT R·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shannon Renae Morris files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →